MedPath
FDA Product

Rizatriptan Benzoate

Product approved by U.S. Food and Drug Administration (US)

Basic Information

Rizatriptan Benzoate

71335-0810

Regulatory Information

71335-0810

ANDA204339

C73584

February 1, 2022

USA

These highlights do not include all the information needed to use rizatriptan benzoate tablets safely and effectively. See full prescribing information for rizatriptan benzoate tablets.Rizatriptan Benzoate Tablets, for oral useInitial U.S. Approval: 1998

HUMAN PRESCRIPTION DRUG LABEL

4

Company Information

171714327

Active Ingredients

LACTOSE MONOHYDRATE

Code: EWQ57Q8I5X

Class Code: IACT

MICROCRYSTALLINE CELLULOSE

Code: OP1R32D61U

Class Code: IACT

STARCH, CORN

Code: O8232NY3SJ

Class Code: IACT

MAGNESIUM STEARATE

Code: 70097M6I30

Class Code: IACT

SILICON DIOXIDE

Code: ETJ7Z6XBU4

Class Code: IACT

FERRIC OXIDE RED

Code: 1K09F3G675

Class Code: IACT

RIZATRIPTAN BENZOATE

Quantity: 5 mg in 1 1

Code: WR978S7QHH

Class Code: ACTIM

Active Moieties

RIZATRIPTAN

Code: 51086HBW8G

© Copyright 2025. All Rights Reserved by MedPath